Innoviva Inc (INVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 91,806 | 89,508 | 99,898 | 77,499 | 85,840 |
| Cost of Goods | 20,116 | 16,501 | 14,912 | 10,971 | 34,914 |
| Gross Profit | 71,690 | 73,007 | 84,986 | 66,528 | 50,926 |
| Operating Expenses | 28,667 | 30,271 | 31,212 | 41,694 | 14,315 |
| Operating Income | 43,139 | 43,237 | 54,686 | 25,805 | 37,525 |
| Interest Expense | 4,749 | 5,807 | 5,802 | 5,851 | 5,952 |
| Other Income | -13,696 | -30,581 | -88,163 | 25,170 | 29,628 |
| Pre-tax Income | 24,694 | 6,849 | -39,279 | 45,124 | 61,201 |
| Income Tax | 4,362 | 5,636 | -4,594 | 8,592 | -330 |
| Net Income Continuous | 20,332 | 1,213 | -34,685 | 36,532 | 61,531 |
| Net Income | $20,332 | $1,213 | $-34,685 | $36,532 | $61,531 |
| EPS Basic Total Ops | 0.32 | 0.02 | -0.55 | 0.58 | 0.96 |
| EPS Basic Continuous Ops | 0.33 | 0.02 | -0.55 | 0.58 | 0.95 |
| EPS Diluted Total Ops | 0.43 | 0.02 | -0.55 | 0.46 | 0.78 |
| EPS Diluted Continuous Ops | 0.42 | 0.02 | -0.55 | 0.43 | 0.71 |
| EPS Diluted Before Non-Recurring Items | 0.57 | 0.02 | 0.68 | N/A | N/A |
| EBITDA(a) | $53,664 | $53,761 | $65,125 | $36,280 | $48,035 |